The Global Alliance for Vaccination and Immunisation47122-04-SOM-02Z-XImmunisation services support (ISS)One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. GAVI’s immunisation services support (ISS) is a flexible programme which countries can use to improve their immunisation performance. Countries have complete control over how and when to use their ISS funding on the condition that DTP3 coverage rates continue to rise. One of the first performance-based programmes of its kind, the ISS programme has two main characteristics aimed at supporting countries to increase their immunisation coverage. Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsCompletion2004-01-012004-12-312004-01-012004-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsSomalia2.0371100 45.3437500Mogadishu379013Commitment379013Disbursement379013World Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-13-SOM-08A-YVaccine Introduction GrantGAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. The pentavalent vaccine, administered in a three-dose schedule, offers protection against five diseases: diphtheria-tetanus-pertussis (DTP), heptatitis B and Haemophilius influenzae type b. Until 2013, GAVI has helped to introduce the pentavalent in 70 of the 73 GAVI-eligible countries, with the aim of reaching all 73 by the end of 2014. GAVI support for pentavalent vaccine is in line with WHO recommendations, for routine infant immunisation and primarily targeting children under one year of age. When approved to introduce a new vaccine, a country will receive a one-time cash grant to support a share of the additional costs related to the new introduction or delivery of the campaign, with the remainder being funded by the Government. The aim of GAVI's vaccine introduction grant is to facilitate the timely and effective implementation of critical activities in the national vaccine introduction plan in advance of a new introduction.Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsCompletion2013-01-012013-12-312013-01-012013-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsSomalia2.0371100 45.3437500Mogadishu304500Commitment304500Disbursement304500World Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-03-SOM-07A-ZInjection safety support (INS)One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. GAVI began offering Injection Safety Support (INS) in mid-2001 to countries that wanted to introduce or increase the use of auto-disable (AD) syringes and safety boxes into their national immunisation programmes for vaccines not supported by GAVI. To date, 71 GAVI-eligible countries have received GAVI’s injection safety support (INS), and by the end of 2009 when the INS window closed, 66 countries reported that they were supporting injection safety practices either through donor support or their own health ministry budgets. GAVI's INS support has improved injection safety practices and almost all recipient countries have found ways to replace and sustain the use of AD syringes and safety boxes. Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsCompletion2003-01-012003-12-312003-01-012003-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsSomalia2.0371100 45.3437500Mogadishu145460Commitment145460Disbursement145460World Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-03-SOM-01Z-YImmunisation services support (ISS)One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. GAVI’s immunisation services support (ISS) is a flexible programme which countries can use to improve their immunisation performance. Countries have complete control over how and when to use their ISS funding on the condition that DTP3 coverage rates continue to rise. One of the first performance-based programmes of its kind, the ISS programme has two main characteristics aimed at supporting countries to increase their immunisation coverage. Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsCompletion2007-01-012007-12-312007-01-012007-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsSomalia2.0371100 45.3437500Mogadishu229987Commitment229987Disbursement229987World Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-1315-SOM-04C-XNew vaccine support (NVS)GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. The pentavalent vaccine, administered in a three-dose schedule, offers protection against five diseases: diphtheria-tetanus-pertussis (DTP), heptatitis B and Haemophilius influenzae type b. Until 2013, GAVI has helped to introduce the pentavalent in 70 of the 73 GAVI-eligible countries, with the aim of reaching all 73 by the end of 2014. GAVI support for pentavalent vaccine is in line with WHO recommendations, for routine infant immunisation and primarily targeting children under one year of age. ImmunisationMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsImplementation2013-01-012015-12-312013-01-012015-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsDecision letters on GAVI support: engagement with countries
The partnership agreement between the GAVI Alliance and the implementing country is called a decision letter. The decision letter is considered a legally binding agreement between GAVI and the country and includes a summary of the agreed support, a review of the implications of GAVI policy and processes to the agreed support, details and data on the approved support (based on information provided by the country in their application), and a short summary of the terms and conditions of GAVI support.
From the development of an application for support through to the decision letter, GAVI and the implementing country work closely together so that the content of the letter depicts the key agreements made by both parties. This process is outlined below.
i. Submission of an application: A country will submit an application for new support in accordance with the criteria provided in the application guidelines.
Throughout application development, GAVI Secretariat staff and Alliance partners proactively support countries in understanding the implications of GAVI policy and processes, as well as in coordinating any technical support related to completing the application.
ii. Pre-assessment: Application pre-assessment is managed by the Secretariat, focusing on validity and consistency of data officially received from countries and coordination with other information sources.
Through this comprehensive screening phase, the Secretariat works closely with the countries to clarify information, verify data, confirm dates, etc., to ensure that all details provided are consistent, clear and complete. These discussions also allow countries to anticipate an outcome and start considering planning for the introduction.
iii. Independent Review Committee (IRC) meeting: The IRC reviews applications, taking into account the pre-assessment reports, and make recommendations to the GAVI Board or Executive Committee.
Following the IRC review, an informal letter is sent to countries to relay details of the IRC recommendation and any related clarifications or further information that may be required of the country by the IRC. While in this communication it is clearly indicated that the IRC outcome is only a recommendation and that the GAVI Board or Executive Committee will need to consider and decide on the IRC recommendation for any result to be considered final, the provision of this information provides the country the opportunity to begin cautious planning and to provide the necessary information to respond to the clarifications required.
iv. Approval: The GAVI Executive Committee will consider and decide on the IRC recommendations. Countries will be notified of the final outcome via a Decision Letter.
In 2013, the decision letter will be replaced with a partnership framework agreement (PFA). The PFA also serves as a legally binding document with countries and is designed to improve the ease for countries to understand the GAVI requirements. Countries will be familiar with the content as most of the terms in the PFA have been taken from a variety of existing documents – such as application guidelines, application forms, annual progress reports, decision letters and aide memoires – and reflects GAVI practice in implementing the policies and board decisions.Somalia2.0371100 45.3437500Mogadishu253148324517112190500Commitment2531483Commitment2451711Commitment2190500Disbursement2531483Disbursement2451711United Nations Childrens FundWorld Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultNumber of Infants vaccinated with DTP-HepB-Hib, 10 doses/vial, LiquidTargets & Achievements values stated here were reported at the first submission of the Annual Progress Reports (APR) by the country. These values may vary from the final version of APR available on GAVI's website.GAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-04-SOM-07A-ZInjection safety support (INS)One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. GAVI began offering Injection Safety Support (INS) in mid-2001 to countries that wanted to introduce or increase the use of auto-disable (AD) syringes and safety boxes into their national immunisation programmes for vaccines not supported by GAVI. To date, 71 GAVI-eligible countries have received GAVI’s injection safety support (INS), and by the end of 2009 when the INS window closed, 66 countries reported that they were supporting injection safety practices either through donor support or their own health ministry budgets. GAVI's INS support has improved injection safety practices and almost all recipient countries have found ways to replace and sustain the use of AD syringes and safety boxes. Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsCompletion2004-01-012004-12-312004-01-012004-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsSomalia2.0371100 45.3437500Mogadishu64680Commitment64680Disbursement64680World Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-03-SOM-02Z-XImmunisation services support (ISS)One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. GAVI’s immunisation services support (ISS) is a flexible programme which countries can use to improve their immunisation performance. Countries have complete control over how and when to use their ISS funding on the condition that DTP3 coverage rates continue to rise. One of the first performance-based programmes of its kind, the ISS programme has two main characteristics aimed at supporting countries to increase their immunisation coverage. Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsCompletion2003-01-012003-12-312003-01-012003-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsSomalia2.0371100 45.3437500Mogadishu304500Commitment304500Disbursement304500World Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-1315-SOM-04C-XNew vaccine support (NVS)GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. The pentavalent vaccine, administered in a three-dose schedule, offers protection against five diseases: diphtheria-tetanus-pertussis (DTP), heptatitis B and Haemophilius influenzae type b. Until 2013, GAVI has helped to introduce the pentavalent in 70 of the 73 GAVI-eligible countries, with the aim of reaching all 73 by the end of 2014. GAVI support for pentavalent vaccine is in line with WHO recommendations, for routine infant immunisation and primarily targeting children under one year of age. ImmunisationMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsImplementation2013-01-012015-12-312013-01-012015-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsDecision letters on GAVI support: engagement with countries
The partnership agreement between the GAVI Alliance and the implementing country is called a decision letter. The decision letter is considered a legally binding agreement between GAVI and the country and includes a summary of the agreed support, a review of the implications of GAVI policy and processes to the agreed support, details and data on the approved support (based on information provided by the country in their application), and a short summary of the terms and conditions of GAVI support.
From the development of an application for support through to the decision letter, GAVI and the implementing country work closely together so that the content of the letter depicts the key agreements made by both parties. This process is outlined below.
i. Submission of an application: A country will submit an application for new support in accordance with the criteria provided in the application guidelines.
Throughout application development, GAVI Secretariat staff and Alliance partners proactively support countries in understanding the implications of GAVI policy and processes, as well as in coordinating any technical support related to completing the application.
ii. Pre-assessment: Application pre-assessment is managed by the Secretariat, focusing on validity and consistency of data officially received from countries and coordination with other information sources.
Through this comprehensive screening phase, the Secretariat works closely with the countries to clarify information, verify data, confirm dates, etc., to ensure that all details provided are consistent, clear and complete. These discussions also allow countries to anticipate an outcome and start considering planning for the introduction.
iii. Independent Review Committee (IRC) meeting: The IRC reviews applications, taking into account the pre-assessment reports, and make recommendations to the GAVI Board or Executive Committee.
Following the IRC review, an informal letter is sent to countries to relay details of the IRC recommendation and any related clarifications or further information that may be required of the country by the IRC. While in this communication it is clearly indicated that the IRC outcome is only a recommendation and that the GAVI Board or Executive Committee will need to consider and decide on the IRC recommendation for any result to be considered final, the provision of this information provides the country the opportunity to begin cautious planning and to provide the necessary information to respond to the clarifications required.
iv. Approval: The GAVI Executive Committee will consider and decide on the IRC recommendations. Countries will be notified of the final outcome via a Decision Letter.
In 2013, the decision letter will be replaced with a partnership framework agreement (PFA). The PFA also serves as a legally binding document with countries and is designed to improve the ease for countries to understand the GAVI requirements. Countries will be familiar with the content as most of the terms in the PFA have been taken from a variety of existing documents – such as application guidelines, application forms, annual progress reports, decision letters and aide memoires – and reflects GAVI practice in implementing the policies and board decisions.Somalia2.0371100 45.3437500Mogadishu253148324517112190500Commitment2531483Commitment2451711Commitment2190500Disbursement2531483Disbursement2451711United Nations Childrens FundWorld Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultNumber of Infants vaccinated with DTP-HepB-Hib, 10 doses/vial, LiquidTargets & Achievements values stated here were reported at the first submission of the Annual Progress Reports (APR) by the country. These values may vary from the final version of APR available on GAVI's website.GAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-1015-SOM-10A-YHealth system strengthening (HSS)One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. The objective of GAVI support for Health Systems Strengthening (HSS) is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. As such, it is necessary for applications for HSS support by countries to be based on a strong bottleneck and gap analysis, and present a clear results chain demonstrating the link between proposed activities and improved immunisation outcomes. GAVI’s approach intends to deliver and document results. From 2013, the HSS cash-based funding stream replaces the previous support to Immunisation Services Support (ISS), Health Systems Funding Platform (HSFP) and Civil Society funding. Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsImplementation2011-01-012015-12-312011-01-012015-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsDecision letters on GAVI support: engagement with countries
The partnership agreement between the GAVI Alliance and the implementing country is called a decision letter. The decision letter is considered a legally binding agreement between GAVI and the country and includes a summary of the agreed support, a review of the implications of GAVI policy and processes to the agreed support, details and data on the approved support (based on information provided by the country in their application), and a short summary of the terms and conditions of GAVI support.
From the development of an application for support through to the decision letter, GAVI and the implementing country work closely together so that the content of the letter depicts the key agreements made by both parties. This process is outlined below.
i. Submission of an application: A country will submit an application for new support in accordance with the criteria provided in the application guidelines.
Throughout application development, GAVI Secretariat staff and Alliance partners proactively support countries in understanding the implications of GAVI policy and processes, as well as in coordinating any technical support related to completing the application.
ii. Pre-assessment: Application pre-assessment is managed by the Secretariat, focusing on validity and consistency of data officially received from countries and coordination with other information sources.
Through this comprehensive screening phase, the Secretariat works closely with the countries to clarify information, verify data, confirm dates, etc., to ensure that all details provided are consistent, clear and complete. These discussions also allow countries to anticipate an outcome and start considering planning for the introduction.
iii. Independent Review Committee (IRC) meeting: The IRC reviews applications, taking into account the pre-assessment reports, and make recommendations to the GAVI Board or Executive Committee.
Following the IRC review, an informal letter is sent to countries to relay details of the IRC recommendation and any related clarifications or further information that may be required of the country by the IRC. While in this communication it is clearly indicated that the IRC outcome is only a recommendation and that the GAVI Board or Executive Committee will need to consider and decide on the IRC recommendation for any result to be considered final, the provision of this information provides the country the opportunity to begin cautious planning and to provide the necessary information to respond to the clarifications required.
iv. Approval: The GAVI Executive Committee will consider and decide on the IRC recommendations. Countries will be notified of the final outcome via a Decision Letter.
In 2013, the decision letter will be replaced with a partnership framework agreement (PFA). The PFA also serves as a legally binding document with countries and is designed to improve the ease for countries to understand the GAVI requirements. Countries will be familiar with the content as most of the terms in the PFA have been taken from a variety of existing documents – such as application guidelines, application forms, annual progress reports, decision letters and aide memoires – and reflects GAVI practice in implementing the policies and board decisions.Somalia2.0371100 45.3437500Mogadishu2786791247038725495153738808Commitment2786791Commitment2470387Commitment2549515Commitment3738808Disbursement2786791Disbursement2470387Disbursement2549515World Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-02-SOM-02Z-XImmunisation services support (ISS)One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. GAVI’s immunisation services support (ISS) is a flexible programme which countries can use to improve their immunisation performance. Countries have complete control over how and when to use their ISS funding on the condition that DTP3 coverage rates continue to rise. One of the first performance-based programmes of its kind, the ISS programme has two main characteristics aimed at supporting countries to increase their immunisation coverage. Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsCompletion2002-01-012002-12-312002-01-012002-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsSomalia2.0371100 45.3437500Mogadishu304500Commitment304500Disbursement304500World Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.orgThe Global Alliance for Vaccination and Immunisation47122-0507-SOM-02Z-YImmunisation services support (ISS)One of GAVI’s strategic goals is to “contribute to strengthening the capacity of integrated health systems to deliver immunisation”. The objective of GAVI cash support is to address system bottlenecks to achieve better immunisation outcomes, including coverage and equity. The GAVI approach is results oriented. GAVI’s immunisation services support (ISS) is a flexible programme which countries can use to improve their immunisation performance. Countries have complete control over how and when to use their ISS funding on the condition that DTP3 coverage rates continue to rise. One of the first performance-based programmes of its kind, the ISS programme has two main characteristics aimed at supporting countries to increase their immunisation coverage. Basic health careMultilateralODAUntiedAid grant excluding debt reorganisationCore contributions to multilateral institutionsCompletion2007-01-012008-12-312007-01-012008-12-31Impact AppraisalsObjectivesConditions are available in the decision lettersConditionsBudget DocsContractsTendersPerformances & EvaluationsResults, outcomes and outputsSomalia2.0371100 45.3437500MogadishuWorld Health Organisation - core voluntary contributions account (for technical assitance)The Global Alliance for Vaccination and ImmunisationFederal States & Local GovernmentsFederal States & Local GovernmentsImmunization ResultGAVI Allianceinfo@gavi.org